Steroids with modified ring A or B: screening for potential antiandrogenic and synandrogenic activity.
D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase / Q000378:metabolism; D000726:Androgen Antagonists; D000818:Animals; D003525:Cyclosteroids / Q000494:pharmacology; D003600:Cytosol / Q000378:metabolism; D013196:Dihydrotestosterone / Q000378:metabolism; D006718:Homosteroids / Q000494:pharmacology*; D066298:In Vitro Techniques; D008297:Male; D011467:Prostate / Q000378:metabolism; D051381:Rats; D011944:Receptors, Androgen / Q000378:metabolism; D012669:Seminal Vesicles / Q000187:drug effects; D012738:Sex Hormone-Binding Globulin / Q000378:metabolism; D013256:Steroids / Q000378:metabolism; D013329:Structure-Activity Relationship; D045165:Testosterone Congeners
D000726:Androgen Antagonists; D003525:Cyclosteroids; D006718:Homosteroids; D011944:Receptors, Androgen; D012738:Sex Hormone-Binding Globulin; D013256:Steroids; D045165:Testosterone Congeners; D013196:Dihydrotestosterone; D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase